| Bioactivity | VO-OHPic is a reversible, noncompetitive and selective PTEN inhibitor with an IC50 of 46 nM. VO-OHPic attenuates apoptosis, adverse cardiac remodeling, and pro-inflammatory M1 macrophages in doxorubicin-induced cardiomyopathy. VO-OHPic inhibits autophagy[1][2][3]. |
| Name | VO-OHPic |
| CAS | 675848-25-6 |
| Formula | C12H10N2O8V |
| Molar Mass | 361.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
VO-OHPic
CAS: 675848-25-6 F: C12H10N2O8V W: 361.16
VO-OHPic is a reversible, noncompetitive and selective PTEN inhibitor with an IC50 of 46 nM. VO-OHPic attenuates apoptos
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.